Melanoma represents a complex and evolving disease spectrum, ranging from localised lesions to highly aggressive metastatic disease , often requiring timely diagnosis and coordinated care. Advances in immuno-oncology and multidisciplinary treatment approaches have significantly improved patient outcomes, yet challenges in early recognition and optimal management persist. To discuss these essential principles, Bristol-Myers Squibb ® , India invites you to an exclusive session under the lecture series “ Reimagine Melanoma Care: Unlocking Novel IO pathway with LAG‑3 & PD‑1 Blockade ” Join expert Oncologist Dr.
Chandrakanth M V for session 1 on “ Melanoma Disease Spectrum and Multidisciplinary Management ” on Saturday , 2 nd May 2026 , from 7:00 PM to 8:00 PM IST . Don’t Miss This Insightful Session! ##DISCLAIMER## The content provided on Docplexus is intended for educational purposes…
